The potential of a placebo/nocebo effect in pharmacogenetics

Public Health Genomics

Volumn 12, Issue 3, 2009, Pages 158-162

  Haga, S B ^a   Warner, L R ^a   O'Daniel, J ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

Adverse outcome; Nocebo effect; Pharmacogenetic testing; Placebo effect

Indexed keywords

PLACEBO; DRUG;

CLINICAL RESEARCH; DRUG RESPONSE; ENVIRONMENTAL FACTOR; HEALTH PRACTITIONER; HUMAN; MEDICAL INFORMATION; PATIENT CARE; PHARMACOGENETICS; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; ARTICLE; CLINICAL TRIAL; PLACEBO EFFECT; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOGENETICS; PLACEBO EFFECT; TREATMENT OUTCOME;

EID: 64549123133     PISSN: 16624246     EISSN: None     Source Type: Journal    
DOI: 10.1159/000189628     Document Type: Review

References (59)

1. Chaput de Saintonge DM, Herxheimer A: Harnessing placebo effects in health care. Lancet 1994;344:995-998.
2. Price D, Finniss D, Benedetti F: A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol 2008;59:565-590.
3. Kennedy WP: The nocebo reaction. Med World 1961;91:203-205.
4. Papakostas YG, Daras MD: Placebos, placebo effect and the response to the healing situation: the evolution of a concept. Epilepsia 2001;42:1614-1625.
5. Benedetti F: How the doctor's words affect the patient's brain. Eval Health Prof 2002;25:369-386.
6. Benson H, Friedman R: Harnessing the power of the placebo effect and renaming it 'remembered wellness.' Annu Rev Med 1996;47:193-199.
7. Ernst E, Resch KL: Concept of true and perceived placebo effects. BMJ 1995;311:551-553.
8. Kienle GS, Kiene H: The powerful placebo effect: fact or fiction? J Clin Epidemiol 1997;50:1311-1318.
9. Hróbjartsson A, Gøtzsche PC: Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001;344:1594-1602.
10. Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK: Neurobiological mechanisms of the placebo effect. J Neurosci 2005;25:10390-10402.
11. Levine JD, Gordon NC, Fields HL: The mechanisms of placebo analgesia. Lancet 1978;2:654-657.
12. Benedetti F: Cholecystokinin type-A and type-B receptors and their modulation of opioid analgesia. News Physiol Sci 1997;12:263-268.
13. Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, Nichols TE, Stohler CS: Placebo effects mediated by endogenous opioid activity on μ-opioid receptors. J Neurosci 2005;25:7754-7762.
14. Scott D, Stohler C, Egnatuk C, Wang H, Koeppe R, Zubieta JK: Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry 2008;65:220-231.
15. Petrovic P, Kalso E, Petersson KM, Ingvar M: Placebo and opioid analgesia - imaging a shared neuronal network. Science 2002;295:1737-1740.
16. Luparello T, Lyons HA, Bleecker ER, McFadden ER: Influences of suggestion on airway reactivity in asthmatic subjects. Psychosom Med 1968;30:819-825.
17. Lancman ME, Asconape JJ, Craven WJ, Howard G, Penry JK: Predictive value of induction of psychogenic seizures by suggestion. Ann Neurol 1994;35:359-361.
18. Dannecker EA, Price DD, Robinson ME: An examination of the relationships among recalled, expected, and actual intensity and unpleasantness of delayed onset muscle pain. J Pain 2003;4:74-81.
19. Anda R, Williamson D, Jones D, Macera C, Eaker E, Glassman A, Marks J: Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology 1993;4:285-294.
20. Colligan MJ, Murphy LR: Mass psychogenic illness in organizations: an overview. J Occup Psychol 1979;52:77-90.
21. Barsky AJ, Saintfor R, Rogers MP, Borus JF: Nonspecific medication side effects and the nocebo phenomenon. JAMA 2002;287:622-627.
22. Price DD: Psychological and neural mechanisms of the affective dimension of pain. Science 2000;288:1769-1772.
23. Lorenz J, Hauck M, Paur RC, Nakamura Y, Zimmermann R, Bromm B, Angel AK: Cortical correlates of false expectations during pain intensity judgments: a possible manifestation of placebo/nocebo cognitions. Brain Behav Immun 2005;19:283-295.
24. Keltner JR, Furst A, Fan C, Redfern R, Inglis B, Fields HL: Isolating the modulatory effect of expectation on pain transmission: a functional magnetic resonance imaging study. J Neurosci 2006;26:4437-4443.
25. Voudouris NJ, Peck CL, Coleman G: Conditioned placebo responses. J Pers Soc Psychol 1985;48:47-53.
26. Olness K, Ader R: Conditioning as an adjunct in the pharmacotherapy of lupus erythematosus. J Dev Behav Pediat 1992;13:124-125.
27. Giang DW, Goodman AD, Schiffer RB, Mattson DH, Petrie M, Cohen N, Ader R: Conditioning of cyclophosphamide-induced leukopenia in humans. J Neuropsychiatry Clin Neurosci 1996;8:194-201.
28. Goebel MU, Trebst AE, Steiner J, Xie YF, Exton MS, Frede S, Canbay AE, Michel MC, Heemann U, Schedlowski M: Behavioral conditioning of immunosuppression is possible in humans. FASEB J 2002;16:1869-1873.
29. Swartzman LC, Burkel J: Expectations and the placebo effect in clinical drug trials: why we should not turn a blind eye to unblinding, and other cautionary notes. Clin Pharmacol Ther 1998;64:1-7.
30. Price DD, Milling LS, Kirsch I, Duff A, Montgomery GH, Nicholls SS: An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain 1999;83:147-156.
31. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I: Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci 2003;23:4315-4323.
32. McRae C, Cherin E, Yamazaki TG, Diem G, Vo AH, Russell D, Ellgring JH, Fahn S, Greene P, Dillon S, Winfield H, Bjugstad KB, Freed CR: Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch Gen Psychiatry 2004;61:412-420.
33. Bausell RB, Lao L, Bergman S, Lee WL, Berman BM: Is acupuncture analgesia an expectancy effect? Preliminary evidence based on participants' perceived assignments in two placebo-controlled trials. Eval Health Prof 2005;28:9-26.
34. Amanzio M, Benedetti F: Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci 1999;19:484-494.
35. Shapiro AK: Factors contributing to the placebo effect, their implications for psychotherapy. Am J Psychotherapy 1964;18:73-88.
36. Wickramasekera I: A conditioned response model of the placebo effect: predictions from the model;in White L, Tursky B, Schwartz GE (eds): Placebo: Theory, Research, and Mechanisms. New York, Guilford Press, 1985, pp 255-287.
37. Thomas KB: General practice consultations: is there any point in being positive? Br Med J (Clin Res Ed) 1987;294:1200-1202.
38. Pollo A, Amanzio M, Arslanian A, Casadio C, Maggi G, Benedetti F: Response expectancies in placebo analgesia and their clinical relevance. Pain 2001;93:77-84.
39. Benson H: The nocebo effect: history and physiology. Prev Med 1997;26:612-615.
40. O'Daniel JM, McConkie-Rosell A: Test results: comprehension, communication, and counseling;in Sharpe NF, Carter RF (eds): Genetic Testing: Care, Consent, and Liability. New York, Wiley Publishing, Inc., 2006, pp 355-382.
41. Zikmund-Fisher BJ, Fagerlin A, Keeton K, Ubel PA: Does labeling prenatal screening test results as negative or positive affect a woman's responses? Am J Obstet Gynecol 2007;197:528.e1-6
42. Rothman AJ, Salovey P, Antone C, Keough K, Drake Martin C: The influence of message framing on intentions to perform health behaviors. J Exp Social Psychology 1993;29:408-433.
43. Wragg JA, Robinson EJ, Lilford RJ: Information presentation and decisions to enter clinical trials: a hypothetical trial of hormone replacement therapy. Soc Sci Med 2000;51:453-462.
44. Welkenhuysen M, Evers-Kiebooms G, d'Ydewalle G: The language of uncertainty in genetic risk communication framing and verbal versus numerical information. Patient Educ Couns 2001;43:179-187.
45. McDonald IG, Guyatt GH, Gutman JM, Jelinek VM, Fox P, Daly J: The contribution of a non-invasive test to clinical care. The impact of echocardiography on diagnosis, management and patient anxiety. J Clin Epidemiol 1988;41:151-161.
46. Sox HC, Margulies I, Sox CH: Psychologically mediated effects of diagnostic tests. Ann Int Med 1981;95:680-685.
47. Fitzpatrick R, Hopkins A, Harvard-Watts O: Social dimensions of healing: a longitudinal study of outcomes of medical management of headaches. Soc Sci Med 1983;17:501-510.
48. McDonald IG, Daly J, Jelinek VM, Panetta F, Gutman JM: Opening Pandora's box: the unpredictability of reassurance by a normal test result. BMJ 1996;313:329-332.
49. Fitzpatrick R: Telling patients there is nothing wrong. BMJ 1996;313:311-312.
50. O'Connor AM, Fiset V, DeGrasse C, Graham ID, Evans W, Stacey D, Laupacis A, Tugwell P: Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J Natl Cancer Inst Monogr 1999;25:67-80.
51. Lipkus IM, Crawford Y, Fenn K, Biradavolu M, Binder RA, Marcus A, Mason M: Testing different formats for communicating colorectal cancer risk. J Health Commun 1999;4:311-324.
52. Sachs L, Taube A, Tishelman C: Risk in numbers - difficulties in the transformation of genetic knowledge from research to people - the case of hereditary cancer. Acta Oncol 2001;40:445-453.
53. Siegrist M, Orlow P, Keller C: The effect of graphical and numerical presentation of hypothetical prenatal diagnosis results on risk perception. Med Decis Making 2008;28:567-674.
54. Hopwood P, Howell A, Lalloo F, Evans G: Do women understand the odds? Risk perceptions and recall of risk information in women with a family history of breast cancer. Community Genet 2003;6:214-223.
55. Kessel N: Reassurance. Lancet 1979;1:1128-1133.
56. Bruster S, Jarman B, Bosanquet N, Weston D, Erens R, Delbanco T: National survey of hospital patients. BMJ 1994;309:1542-1549.
57. Michie S, French D, Allanson A, Bobrow M, Marteau T: Information recall in genetic counselling: a pilot study of its assessment. Patient Educ Couns 1997;32:93-100.
58. Watson M, Duvivier V, Wade Walsh M, Ashley S, Davidson J, Papaikonomou M, Murday V, Sacks N, Eeles R: Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet 1998;35:731-738.
59. Michie S, Thompson M, Hankins M: To be reassured or to understand? A dilemma in communicating normal cervical screening results. Br J Health Psychol 2004;9:113-123.